Gallstone disease: Physicochemical research sheds new light on an old disease and points the way to medical therapy

Journal of Hepatology

Volumn 41, Issue 2, 2004, Pages 195-200

  Hofmann, Alan F ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; CHOLESTEROL; PHOSPHATIDYLCHOLINE; URSODEOXYCHOLIC ACID;

BILE; CHOLELITHIASIS; CONCENTRATION (PARAMETERS); CRYSTAL; CRYSTAL STRUCTURE; GALLBLADDER; GALLSTONE; HUMAN; IN VITRO STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SOLUBILIZATION;

EID: 4444363328     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.003     Document Type: Note

References (51)

1. Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968;47:1043-1052.
2. Thudichum JLW. A treatise on gall-stones: their chemistry, pathology, and treatment. London: John Churchill and Sons; 1863.
3. Naunyn B. A treatise of cholelithiasis. London: New Sydenham Soc. Ed; 1896.
4. Ammon HV, Hofmann AF. The Langenbuch paper. I. An historical perspective and comments of the translators. Gastroenterology 1983;85:1426-1433.
5. Cole WH. The development of cholecystography. J Thorac Cardiovasc Surg 1984;88:827-833.
6. Johnston CG, Nakayama F. Solubility of cholesterol and gallstones in metabolic material. Arch Surg 1957;75:436-442.
7. Bourges M, Small DM, Dervichian DG. Biophysics of lipid associations. 3. The quaternary systems lecithin-bile salt-cholesterol-water. Biochim Biophys Acta 1967;144:189-201.
8. Ingelfinger FJ. Digestive disease as a national problem. V. Gallstones. Gastroenterology 1968;55:102-104.
9. McBain MEL, Hutchinson E. Solubilization and related phenomena. New York, NY: Academic Press; 1955. pp. 1-259.
10. Lawrence ASC. The mechanism of detergence. Nature 1959;183:1491-1494.
11. Ekwall P. Association colloids: surface and colloid chemical studies. Svensk Kemisk Tidskrift 1951;63:277-307.
12. Dervichian DG. The physical chemistry of phospholipids. In: Butler J, Huxley H, editors. Progress in biophysics and molecular biology. New York, NY: Academic Press; 1964. p. 263-342.
13. Hegardt FG, Dam H. The solubility of cholesterol in aqueous solution of bile salts and lecithin. Z Ernahr 1971;10:223-233.
14. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-955.
15. Metzger AL, Heymsfield S, Grundy SM. The lithogenic index - a numerical expression for the relative lithogenicity of bile. Gastroenterology 1972;62:499-501.
16. Kuroki S, Cohen BI, Carey MC, Mosbach EH. Rapid computation with the personal computer of the percent cholesterol saturation of bile samples. J Lipid Res 1986;27:442-446.
17. Thomas PJ, Hofmann AF. A simple calculation of the lithogenic index: expressing biliary lipid composition on rectangular coordinates. Gastroenterology 1973;65:698-700.
18. Wang DQ, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute, and hydrophilic bile salt-containing systems. J Lipid Res 1996;37:606-630.
19. Holzbach RT, Marsh M, Olszewski M, Holan K. Cholesterol solubility in bile: evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973;52:1467-1479.
20. Jirsa M, Groen AK. Role of biliary proteins and non-protein factors in kinetics of cholesterol crystallization and gallstone growth. Front Biosci 2001;6:E154-E167.
21. Hjelm Jr RP, Thiyagarajan P, Alkan-Onkyuksel H. Organization of phosphatidylcholine and bile salt in rodlike mixed micelles. J Phys Chem 1992;96:8653-8661.
22. Long MA, Kaler EW, Lee SP. Structural characterization of the micelle-vesicle transition in lecithin-bile salt solutions. Biophys J 1994;67:1733-1742.
23. Cohen DE, Thurston GM, Chamberlin RA, Benedek GB, Carey MC. Laser light scattering evidence for a common wormlike growth structure of mixed micelles in bile salt- and straight-chain detergent phosphatidylcholine aqueous systems: relevance for the micellar structure of bile. Biochemistry 1998;37:14798-14814.
24. Marrink SJ, Mark AE. Molecular dynamics simulations of mixed micelles modeling human bile. Biochemistry 2002;41:5375-5382.
25. Neiderhiser DH, Roth HP. Cholesterol solubilization by solutions of bile salts and bile salts plus lecithin. Proc Soc Exp Biol Med 1968;128:221-225.
26. Mazer NA, Schurtenberger P, Carey MC, Preisig R, Weigand K, Kaenzig W. Quasi-elastic light scattering studies of native hepatic bile from the dog: comparison with aggregative behavior of model biliary lipid systems. Biochemistry 1984;23:1994-2005.
27. Donovan JM, Jackson AA. Rapid determination by centrifugal ultrafiltration of inter-mixed micellar/vesicular (non-lecithin-associated) bile salt concentrations in model bile: influence of Donnan equilibrium effects. J Lipid Res 1993;34:1121-1129.
28. Liu CL, Jain UK, Lee PH, Mazer NA, Higuchi WI. Cholesterol thermodynamic activity, quasielastic light scattering, and polarizing microscopy studies in aqueous taurocholate-lecithin solutions supersaturated with cholesterol. J Colloid Interface Sci 1994;165:411-424.
29. Liu CL, Higuchi WI. Cholesterol crystallite nucleation in supersaturated model biles from a thermodynamic standpoint. Biochim Biophys Acta 2002;1588:15-25.
30. Corradini SG, Arancia G, Calcabrini A, Della Guardia P, Baiocchi L, Nistri A, et al. Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae. J Hepatol 1995;22:642-657.
31. Hofmann AF, editor. The Physical Chemistry of Bile in Health and Disease (The Kroc Foundation - Conference Proceedings). Hepatology, 4.; 1984. p. 1S-252S. (Supplement).
32. Strasberg SM, Hofmann AF, editors. Biliary Cholesterol Transport and Precipitation (Symposium on Gallstone Formation - CIBA-Geigy). Hepatology, 12.; 1990. p. 1S-244S. (Supplement).
33. Forgacs IC, Maisey MN, Murphy GM, Dowling RH. Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology 1984;87:299-307.
34. Pauletski J, Paumgartner G. Review article: defects in gall-bladder motor function - role in gallstone formation and recurrence. Aliment Pharmacol Ther 2000;32-34.
35. Xiao ZL, Chen Q, Amaral J, Biancani P, Behar J. Defect of receptor-G protein coupling in human gallbladder with cholesterol stones. Am J Physiol Gastrointest Liver Physiol 2000;278:G251-G258.
36. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996;26:343-352.
37. Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JL. Dissolution of cholesterol gallstones by chenodeoxycholic acid. New Engl J Med 1972;286:1-8.
38. Nakagawa S, Makino I, Ishazaki T, Dohi I. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Lancet 1977;2:367-369.
39. Leopold GR, Amberg J, Gosink BB, Mittelstaedt C. Gray scale ultrasonic cholecystography: a comparison with conventional radiographic techniques. Radiology 1976;121:445-448.
40. National Institutes of Health Consensus, National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy. Am J Surg 1993;165:390-398.
41. Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MAL, Linner JH, et al. A Multi-center, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169:91-97.
42. Hofmann AF. Primary and secondary prevention of gallstone disease: implications for patient management and research priorities. Am J Surg 1993;165:541-548.
43. Reihner E, Angelin B, Bjorkhem I, Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res 1991;32:469-475.
44. Berr F, Kullak-Ublick GA, Paumgartner G, Münzing W, Hylemon PB. 7α-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996;111:1611-1620.
45. Gustaffson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones. Eur J Clin Invest 2000;30:1099-1106.
46. Ito T, Kawata S, Imai Y, Kakimoto H, Trzaskos JM, Matsuzawa Y. Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol. Gastroenterology 1996;110:1619-1627.
47. Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004;126:322-342.
48. Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003;125:452-459.
49. Graf GA, Yu L, Li WP, Gerard R, Tuma PL, Cohen JC, et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 2003;278:48275-48282.
50. Lammert F, Wang DQ, Wittenburg H, Bouchard G, Hillebrandt S, Taenzler B, et al. Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice. Hepatology 2002;36:1145-1154.
51. Hofmann AF. Gallstone disease: physicochemical research joins empirical surgery. Gastroenterology 1997;113:341-344.